Gaviscon 500mg chewable tablets peppermint

Main information

  • Trade name:
  • Gaviscon 500mg chewable tablets peppermint
  • Dosage:
  • 100mg ; 25mg ; 500mg ; 170mg
  • Pharmaceutical form:
  • Chewable tablet
  • Administration route:
  • Oral
  • Class:
  • No Controlled Drug Status
  • Prescription type:
  • Never Valid To Prescribe As A VMP
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • Gaviscon 500mg chewable tablets peppermint
    United Kingdom
  • Language:
  • English

Therapeutic information

  • Product summary:
  • BNF:

Status

  • Source:
  • eMC
  • Authorization number:
  • PL 00063/0627
  • Last update:
  • 11-07-2019

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation